Iambic Therapeutics, Inc. IAM
13.18 USD +3.01 (+29.60%)
Nov 9, 2026, 2:44 PM EST
9.90 Day range 13.28
9.60 52-week range 25.00
- YTD
- -30.30%
- 1 year
- -30.30%
3M chart
Chart tools
Signals (1)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Nov 6, 2026 | 3 days ago |
Technical signals
Every overlay, indicator and candlestick pattern on the daily chart, weighted into one reading per group.
Overlay
Buy
- sell
- 3
- neutral
- 27
- buy
- 6
Indicator
Sell
- sell
- 2
- neutral
- 27
- buy
- 0
Candlestick
Buy
- sell
- 1
- neutral
- 53
- buy
- 7
| Indicator | Name | Value | Signal |
|---|---|---|---|
| SMA (5) | SMA | 12.37 | Bullish |
| EMA (5) | EMA | 12.40 | Bullish |
| SMA (10) | SMA | 13.13 | Bullish |
| EMA (10) | EMA | 13.26 | Bearish |
| SMA (20) | SMA | — | Neutral |
| EMA (20) | EMA | — | Neutral |
| SMA (21) | SMA | — | Neutral |
| EMA (21) | EMA | — | Neutral |
| SMA (25) | SMA | — | Neutral |
| EMA (25) | EMA | — | Neutral |
| SMA (30) | SMA | — | Neutral |
| EMA (30) | EMA | — | Neutral |
| SMA (50) | SMA | — | Neutral |
| EMA (50) | EMA | — | Neutral |
| SMA (63) | SMA | — | Neutral |
| EMA (63) | EMA | — | Neutral |
| SMA (75) | SMA | — | Neutral |
| EMA (75) | EMA | — | Neutral |
| SMA (100) | SMA | — | Neutral |
| EMA (100) | EMA | — | Neutral |
| SMA (125) | SMA | — | Neutral |
| EMA (125) | EMA | — | Neutral |
| SMA (150) | SMA | — | Neutral |
| EMA (150) | EMA | — | Neutral |
| SMA (200) | SMA | — | Neutral |
| EMA (200) | EMA | — | Neutral |
| VWAP (HLC/3) | VWAP | 16.66 | Bullish |
| ZZ (0.05) | ZigZag | 13.13 | Neutral |
| BBANDS (20, 2) | Bollinger Bands | — | Neutral |
| PSAR (0.02, 0.2) | Parabolic SAR | 17.55 | Bearish |
| KAMA (10) | Kaufman Adaptive Moving Average | 13.01 | Bullish |
| MAMA (0.5, 0.05) | MESA Adaptive Moving Average | — | Neutral |
| WMA (10) | Weighted Moving Average | 12.65 | Bullish |
| TEMA (10) | Triple Exponential Moving Average | — | Neutral |
| TRIMA (10) | Triangular Moving Average | 13.15 | Bearish |
| T3 (10) | Triple Exponential Moving Average | — | Neutral |